Fas/CD95-Induced Chemokines Can Serve as " Find-Me" Signals for Apoptotic Cells

Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland
Molecular cell (Impact Factor: 14.02). 02/2013; 49(6). DOI: 10.1016/j.molcel.2013.01.025
Source: PubMed


Apoptosis is commonly thought to represent an immunologically silent or even anti-inflammatory mode of cell death, resulting in cell clearance in the absence of explicit activation of the immune system. However, here we show that Fas/CD95-induced apoptosis is associated with the production of an array of cytokines and chemokines, including IL-6, IL-8, CXCL1, MCP-1, and GMCSF. Fas-induced production of MCP-1 and IL-8 promoted chemotaxis of phagocytes toward apoptotic cells, suggesting that these factors serve as "find-me" signals in this context. We also show that RIPK1 and IAPs are required for optimal production of cytokines and chemokines in response to Fas receptor stimulation. Consequently, a synthetic IAP antagonist potently suppressed Fas-dependent expression of multiple proinflammatory mediators and inhibited Fas-induced chemotaxis. Thus, in addition to provoking apoptosis, Fas receptor stimulation can trigger the secretion of chemotactic factors and other immunologically active proteins that can influence immune responsiveness toward dying cells.

Download full-text


Available from: Conor Henry, Jan 27, 2014
  • Source
    • "Apoptosis Release of chemotactic factors by apoptotic cells. Pro-inflammatory KC, MCP-1, IL-8 Cullen et al., 2013. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Microbial infection and tissue injury are well established as the two major drivers of inflammation. However, although it is well established that necrotic cell death can trigger or potentiate inflammation, precisely how this is achieved still remains relatively obscure. Certain molecules, which have been dubbed ‘damage-associated molecular patterns’ (DAMPs) or alarmins, are thought to promote inflammation upon release from necrotic cells. However, the precise nature and relative potency of DAMPs, compared to conventional pro-inflammatory cytokines or pathogen-associated molecular patterns (PAMPs), remains unclear. How different modes of cell death impact on the immune system also requires further clarification. Apoptosis has long been regarded as a non-inflammatory or even anti-inflammatory mode of cell death, but recent studies suggest that this is not always the case. Necroptosis is a programmed form of necrosis that is engaged under certain conditions when caspase activation is blocked. Necroptosis is also regarded as a highly pro-inflammatory mode of cell death but there has been little explicit examination of this issue. Here we discuss the inflammatory implications of necrosis, necroptosis and apoptosis and some of the unresolved questions concerning how dead cells influence inflammatory responses.
    Full-text · Article · Aug 2014 · Biological Chemistry
  • Source
    • "Some apoptotic cell-derived ‘find me’ signals are capable of recruiting neutrophils, which would result in an undesirable phlogistic reaction to apoptotic cells. Some examples of these signals are IL-8 released from Fas-mediated apoptosis of epithelial cells or LPC-induced IL-8 production in endothelial cells.21,26 Lactoferrin may provide an answer as to why neutrophilic infiltrates are not found at sites of persistent apoptosis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Apoptosis is an important cell death mechanism by which multicellular organisms remove unwanted cells. It culminates in a rapid, controlled removal of cell corpses by neighboring or recruited viable cells. Whilst many of the molecular mechanisms that mediate corpse clearance are components of the innate immune system, clearance of apoptotic cells is an anti-inflammatory process. Control of cell death is dependent on competing pro-apoptotic and anti-apoptotic signals. Evidence now suggests a similar balance of competing signals is central to the effective removal of cells, through so called ‘eat me’ and ‘don’t eat me’ signals. Competing signals are also important for the controlled recruitment of phagocytes to sites of cell death. Consequently recruitment of phagocytes to and from sites of cell death can underlie the resolution or inappropriate propagation of cell death and inflammation. This article highlights our understanding of mechanisms mediating clearance of dying cells and discusses those mechanisms controlling phagocyte migration and how inappropriate control may promote important pathologies.
    Full-text · Article · Oct 2013 · Journal of Cell Death
  • Source
    • "FAS signaling also favors the secretion of multiple cytokines and chemokines, including CXCL1, CCL2, IL-6, and IL-8. IL-8 not only promotes an ATP-independent chemotactic response of phagocytes toward apoptotic cells (Cullen et al., 2013), but also stimulates CRT exposure (Sukkurwala et al., 2013). Therefore, it is possible that death receptor signaling can induce hallmarks of immunogenic cell death indirectly, via the production of IL-8. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Conventional chemotherapeutics and targeted antineoplastic agents have been developed based on the simplistic notion that cancer constitutes a cell-autonomous genetic or epigenetic disease. However, it is becoming clear that many of the available anticancer drugs that have collectively saved millions of life-years mediate therapeutic effects by eliciting de novo or reactivating pre-existing tumor-specific immune responses. Here, we discuss the capacity of both conventional and targeted anticancer therapies to enhance the immunogenic properties of malignant cells and to stimulate immune effector cells, either directly or by subverting the immunosuppressive circuitries that preclude antitumor immune responses in cancer patients. Accumulating evidence indicates that the therapeutic efficacy of several antineoplastic agents relies on their capacity to influence the tumor-host interaction, tipping the balance toward the activation of an immune response specific for malignant cells. We surmise that the development of successful anticancer therapies will be improved and accelerated by the immunological characterization of candidate agents.
    Full-text · Article · Jul 2013 · Immunity
Show more